Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
1998 2
2003 1
2005 1
2006 4
2007 2
2008 4
2009 2
2010 4
2011 3
2013 1
2014 1
2015 2
2016 2
2017 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Assessing vaccine potency using TCRmimic antibodies.
Neethling FA, Ramakrishna V, Keler T, Buchli R, Woodburn T, Weidanz JA. Neethling FA, et al. Among authors: weidanz ja. Vaccine. 2008 Jun 13;26(25):3092-102. doi: 10.1016/j.vaccine.2008.02.025. Epub 2008 Feb 25. Vaccine. 2008. PMID: 18353510
Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.
Kaabinejadian S, McMurtrey CP, Kim S, Jain R, Bardet W, Schafer FB, Davenport JL, Martin AD, Diamond MS, Weidanz JA, Hansen TH, Hildebrand WH. Kaabinejadian S, et al. Among authors: weidanz ja. J Immunol. 2016 May 15;196(10):4263-73. doi: 10.4049/jimmunol.1501821. Epub 2016 Apr 20. J Immunol. 2016. PMID: 27183642 Free PMC article.
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.
Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald G, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH. Patterson AM, et al. Among authors: weidanz ja. Mol Cancer Ther. 2016 Feb;15(2):313-22. doi: 10.1158/1535-7163.MCT-15-0658. Epub 2015 Dec 30. Mol Cancer Ther. 2016. PMID: 26719579 Free PMC article.
31 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page